3.4.7 Chiron Vaccine

Chiron is developing a genetically engineered HCV vaccine,. Small clinical trials with humans in collaboration with CSL Ltd (see III.4.8), and St Louis University, are now being conducted. The company is studying two possible vaccines, including a recombinant vaccine and a second-generation DNA vaccine to induce a cellular immune response ( www.chiron.com).